YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Roche Bids Again for Illumina?


December 21, 2012 | A Swiss newspaper is reporting that Roche and Illumina may have come to a purchase agreement, eight months after Illumina rejected Roche's last proposed bid. The two companies will announce a January $66/share sale price, the paper reported, though it said the information couldn't be verified. Analysts are very skeptical and neither company will comment. Bloomberg 

Update: Matthew Herper at Forbes contends that if Roche is bidding again for Illumina, Jay Flatley, Illumina's CEO, is the main asset. Forbes

View Next Related Story
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.